Gene: PIAS1
Official Full Name: protein inhibitor of activated STAT 1provided by HGNC
Gene Summary: This gene encodes a member of the protein inhibitor of activated STAT (PIAS) family. PIAS proteins function as SUMO E3 ligases and play important roles in many cellular processes by mediating the sumoylation of target proteins. This protein plays a central role as a transcriptional coregulator of numerous cellular pathways includign the STAT1 and nuclear factor kappaB pathways. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11218 | PIAS1 Knockout cell line (HeLa) | Human | PIAS1 | 1:3~1:6 | Negative | Online Inquiry |
KO11219 | PIAS1 Knockout cell line (HCT 116) | Human | PIAS1 | 1:2~1:4 | Negative | Online Inquiry |
KO11220 | PIAS1 Knockout cell line (HEK293) | Human | PIAS1 | 1:3~1:6 | Negative | Online Inquiry |
PIAS1 Gene Knockout Cell Lines are genetically engineered cell lines where the PIAS1 gene has been inactivated or "knocked out" to study its functional role in cellular processes. PIAS1 (Protein Inhibitor of Activated STAT1) is a crucial regulator of the JAK-STAT signaling pathway, influencing immune responses and cell differentiation. The knockout of this gene allows researchers to investigate the specific contributions of PIAS1 in various biological systems, including its impact on signal transduction and gene expression modulation.
These cell lines are constructed using cutting-edge CRISPR-Cas9 technology, which facilitates precise genomic editing. By disrupting the PIAS1 gene, scientists can assess downstream effects on cellular pathways, providing insights into the mechanistic roles of PIAS1 in oncogenesis, immune response, and neurobiology. The ability to study these intricate biological interactions is vital for elucidating disease mechanisms and screening for potential therapeutic targets.
The scientific importance of PIAS1 Gene Knockout Cell Lines extends to both basic research and clinical applications. They serve as powerful tools for exploring the roles of PIAS1 in cancer biology and autoimmune diseases, enabling the development of targeted therapies. Additionally, these cell lines can help to advance the understanding of therapeutic resistance mechanisms, as PIAS1 has been implicated in mediating the response to various treatments.
Compared to alternative cellular models, PIAS1 Gene Knockout Cell Lines offer superior specificity in examining the effects associated with PIAS1 absence, thereby reducing confounding variables that may arise in wild-type systems. This specificity enhances the reliability of experimental results, making them invaluable for researchers focused on elucidating the complexities of gene function and regulation.
In summary, PIAS1 Gene Knockout Cell Lines represent a significant advancement in the toolkit available to researchers and clinicians. Their unique capacity to provide insights into gene function and its contributions to disease pathology makes them a critical resource for cutting-edge biotechnological research. Our company, renowned for its commitment to quality and innovation in biological products, provides these cell lines with exceptional reliability and support, ensuring that scientists have the best tools for their groundbreaking work.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.